Bristol-Myers Squibb to Acquire Mirati Therapeutics for $4.8 Billion in Cash: A Game-Changing Move in the Cancer Drug Industry
Bristol-Myers Squibb to Acquire Mirati Therapeutics for $4.8 Billion Introduction Bristol-Myers Squibb is set to acquire cancer drugmaker Mirati Therapeutics ...